Patel Parin J, Borovskiy Yuliya, Killian Anthony, Verdino Ralph J, Epstein Andrew E, Callans David J, Marchlinski Francis E, Deo Rajat
St. Vincent Medical Group, Division of Cardiology, Indianapolis, Indiana; Section of Electrophysiology, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Section of Electrophysiology, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Heart Rhythm. 2016 Feb;13(2):527-35. doi: 10.1016/j.hrthm.2015.11.008. Epub 2015 Nov 10.
The QT interval measures cardiac repolarization, and prolongation is associated with adverse cardiovascular outcomes and death. The exponential Bazett correction formula overestimates the QT interval during tachycardia.
We evaluated 4 formulas of QT interval correction in individuals with sinus tachycardia for the identification of coronary artery disease, heart failure, and mortality.
The Penn Atrial Fibrillation Free study is a large cohort study of patients without atrial fibrillation. The present study examined 6723 Penn Atrial Fibrillation Free study patients without a history of heart failure and with baseline sinus rate ≥100 beats/min. Medical records were queried for index clinical parameters, incident cardiovascular events, and all-cause mortality. The QT interval was corrected by using Bazett (QT/RR(0.5)), Fridericia (QT/RR(0.33)), Framingham [QT + 0.154 * (1000 - RR)], and Hodges (QT + 105 * (1/RR - 1)) formulas.
In 6723 patients with a median follow-up of 4.5 years (interquartile range 1.9-6.4 years), the annualized cardiovascular event rate was 2.3% and the annualized mortality rate was 2.2%. QT prolongation was diagnosed in 39% of the cohort using the Bazett formula, 6.2% using the Fridericia formula, 3.7% using the Framingham formula, and 8.7% using the Hodges formula. Only the Hodges formula was an independent risk marker for death across the range of QT values (highest tertile: hazard ratio 1.26; 95% confidence interval 1.03-1.55).
Although all correction formulas demonstrated an association between QTc values and cardiovascular events, only the Hodges formula identified one-third of individuals with tachycardia that are at higher risk of all-cause mortality. Furthermore, the Bazett correction formula overestimates the number of patients with a prolonged QT interval and was not associated with mortality. Future work may validate these findings and result in changes to automated algorithms for QT interval assessment.
QT间期用于测量心脏复极,其延长与不良心血管结局及死亡相关。指数形式的Bazett校正公式在心动过速时会高估QT间期。
我们评估了4种用于窦性心动过速个体的QT间期校正公式,以识别冠状动脉疾病、心力衰竭及死亡率。
宾夕法尼亚无房颤研究是一项针对无房颤患者的大型队列研究。本研究纳入了6723例无心力衰竭病史且基线窦性心率≥100次/分钟的宾夕法尼亚无房颤研究患者。查询病历以获取指标临床参数、心血管事件及全因死亡率。QT间期通过Bazett公式(QT/RR(0.5))、Fridericia公式(QT/RR(0.33))、弗雷明汉公式[QT + 0.154 * (1000 - RR)]和霍奇斯公式(QT + 105 * (1/RR - 1))进行校正。
在6723例患者中,中位随访时间为4.5年(四分位间距1.9 - 6.4年),年化心血管事件发生率为2.3%,年化死亡率为2.2%。使用Bazett公式时,队列中39%的患者被诊断为QT延长;使用Fridericia公式时为6.2%;使用弗雷明汉公式时为3.7%;使用霍奇斯公式时为8.7%。在整个QT值范围内,只有霍奇斯公式是死亡的独立风险标志物(最高三分位数:风险比1.26;95%置信区间1.03 - 1.55)。
尽管所有校正公式都显示QTc值与心血管事件之间存在关联,但只有霍奇斯公式识别出了三分之一心动过速且全因死亡风险较高的个体。此外,Bazett校正公式高估了QT间期延长患者的数量,且与死亡率无关。未来的研究可能会验证这些发现,并导致QT间期评估自动化算法的改变。